← All companies

CWLX

C21 Investments Inc.

CWLXF OTC Medicinal Chemicals & Botanical Products EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

$32.6M

Net income (TTM)

-$3.24M

EPS (TTM)

$-0.03

P/E ratio

—

Dividend yield

—

Free cash flow

$1.12M

Cash

—

Total assets

$54.4M

Gross margin

41.7%

52-week range

—

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 9, 2026 6-K FORM 6-K Jun 22, 2026 6-K FORM 6-K Jun 15, 2026 20-F FORM 20-F Jun 12, 2026 6-K FORM 6-K Jun 12, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Sep 9, 2025 6-K FORM 6-K Sep 8, 2025 6-K FORM 6-K Sep 5, 2025 6-K FORM 6-K Aug 25, 2025 6-K/A FORM 6-K/A Aug 21, 2025 6-K FORM 6-K Aug 14, 2025 6-K FORM 6-K Aug 8, 2025 6-K FORM 6-K Jul 31, 2025 6-K FORM 6-K Jul 31, 2025 6-K FORM 6-K Jul 7, 2025 6-K FORM 6-K Jun 24, 2025 20-F FORM 20-F Jun 23, 2025 6-K FORM 6-K May 23, 2025 20-F/A FORM 20-F/A Mar 7, 2025 6-K FORM 6-K Feb 19, 2025 6-K FORM 6-K Jan 30, 2025 6-K FORM 6-K Jan 29, 2025 6-K FORM 6-K Nov 27, 2024 6-K FORM 6-K Nov 19, 2024 6-K FORM 6-K Nov 14, 2024 6-K FORM 6-K Nov 14, 2024 6-K FORM 6-K Oct 30, 2024 6-K FORM 6-K Oct 21, 2024 6-K FORM 6-K Sep 27, 2024 6-K FORM 6-K Sep 23, 2024 6-K FORM 6-K Aug 16, 2024 20-F/A FORM 20-F/A Aug 16, 2024 6-K FORM 6-K Aug 16, 2024 20-F FORM 20-F Aug 8, 2024 6-K FORM 6-K Aug 2, 2024 6-K FORM 6-K Aug 2, 2024